Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shengmeng Di

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Science China. Life Sciences|March 13, 2016
Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospectsShengmeng Di, Zonghai Li
Electromagnetic Biology and Medicine|November 4, 2011
Selection of suitable reference genes from bone cells in large gradient high magnetic field based on GeNorm algorithmShengmeng Di, Zongcheng Tian, Airong Qian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 5, 2022
Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signalingMin Zhou, Muhua Chen, Bizhi Shi, et al.
Frontiers in Oncology|May 7, 2019
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T CellsShengmeng Di, Min Zhou, Zeyan Pan, et al.
Acta Biochimica Et Biophysica Sinica|July 7, 2009
cDNA microarray reveals the alterations of cytoskeleton-related genes in osteoblast under high magneto-gravitational environmentAirong Qian, Shengmeng Di, Xiang Gao, et al.
International Journal of Radiation Biology|May 31, 2012
Large gradient high magnetic field affects FLG29.1 cells differentiation to form osteoclast-like cellsShengmeng Di, Zongcheng Tian, Airong Qian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2018
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular CarcinomaMin Yu, Hong Luo, Mingliang Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2019
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular CarcinomaXiuqi Wu, Hong Luo, Bizhi Shi, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|March 25, 2009
[Cloning of silkworm 3-hydroxyisobutyrate dehydrogenase gene and its expression patterns analysis in simulated weightless environment]Zongcheng Tian, Bo Zhou, Airong Qian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2019
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular CarcinomaYing Liu, Shengmeng Di, Bizhi Shi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Science China. Life Sciences|March 13, 2016
Treatment of solid tumors with chimeric antigen receptor-engineered T cells: current status and future prospectsShengmeng Di, Zonghai Li
Electromagnetic Biology and Medicine|November 4, 2011
Selection of suitable reference genes from bone cells in large gradient high magnetic field based on GeNorm algorithmShengmeng Di, Zongcheng Tian, Airong Qian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 5, 2022
Radiation enhances the efficacy of EGFR-targeted CAR-T cells against triple-negative breast cancer by activating NF-κB/Icam1 signalingMin Zhou, Muhua Chen, Bizhi Shi, et al.
Frontiers in Oncology|May 7, 2019
Combined Adjuvant of Poly I:C Improves Antitumor Effects of CAR-T CellsShengmeng Di, Min Zhou, Zeyan Pan, et al.
Acta Biochimica Et Biophysica Sinica|July 7, 2009
cDNA microarray reveals the alterations of cytoskeleton-related genes in osteoblast under high magneto-gravitational environmentAirong Qian, Shengmeng Di, Xiang Gao, et al.
International Journal of Radiation Biology|May 31, 2012
Large gradient high magnetic field affects FLG29.1 cells differentiation to form osteoclast-like cellsShengmeng Di, Zongcheng Tian, Airong Qian, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 18, 2018
Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular CarcinomaMin Yu, Hong Luo, Mingliang Fan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 13, 2019
Combined Antitumor Effects of Sorafenib and GPC3-CAR T Cells in Mouse Models of Hepatocellular CarcinomaXiuqi Wu, Hong Luo, Bizhi Shi, et al.
Sheng Wu Gong Cheng Xue Bao = Chinese Journal of Biotechnology|March 25, 2009
[Cloning of silkworm 3-hydroxyisobutyrate dehydrogenase gene and its expression patterns analysis in simulated weightless environment]Zongcheng Tian, Bo Zhou, Airong Qian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 31, 2019
Armored Inducible Expression of IL-12 Enhances Antitumor Activity of Glypican-3-Targeted Chimeric Antigen Receptor-Engineered T Cells in Hepatocellular CarcinomaYing Liu, Shengmeng Di, Bizhi Shi, et al.
Pageof 2